Details

Last Funding Type

Series B

Last Funding Money Raised

$7.25M

Industries

Biopharma,Pharmaceutical,Therapeutics

Founded date

May 1, 2000

Number Of Employee

1 - 10

Operating Status

Close

Pintex Pharmaceuticals, Inc. is a private pharmaceuticals company headquartered in Watertown, MA., that is engaged in the discovery and development of structure-based cancer therapeutics. In particular, the focus of Pintex's research is on the phosphate specific proline isomerase Pin1 enzyme and its key role in cancer. Pintex was founded in May 1999 by Dr. Kun Ping Lu, a Pew scholar at Harvard University, Dr. Walter Gilbert, a Nobel Prize winning professor at Harvard University and Dr. Janusz Sowadski, co-founder of Kinetix Pharmaceuticals, Inc., and a past recipient of the US Supercomputing Award for structure-based kinase inhibitor designs. Pintex was created in order to harness the many years of research and discovery performed and patented by researchers at the Salk Institute for Biological Studies and Harvard University.